TABLE 4.
The roles of let-7d-5p in lung disease.
| Author | Disease | Target/pathway | Role | Expression | Reference |
|---|---|---|---|---|---|
| Chen; Kumar; Mendes-Silva | Alzheimer’s diseaseAlzheimer’s disease | — | — | ↓ | Kumar et al. (2013); Mendes-Silva et al. (2016); Chen et al. (2018) |
| Liguori | Amyotrophic lateral sclerosis | — | — | ↓ | Liguori et al. (2018) |
| Sun | Necrotizing enterocolitis of neonatal rats | LGALS3-dependent TLR4/NF-κB signaling pathway | Anti-inflammatory properties and inhibited intestinal epithelial cell apoptosis | — | Sun et al. (2020) |
| Bagnato; Min | PF | — | — | ↓ | Min et al. (2016); Bagnato et al. (2017) |
| Gasparini; Kumar | NSCLC | — | Biomarker | ↓ | Gasparini et al. (2015); Kumar et al. (2020) |
| Gan | Lung cancer | NAP1L1 | Repress angiogenesis | ↓ | Gan et al. (2022) |
| Ideozu | cystic fibrosis | — | — | ↑ | Ideozu et al. (2019) |
| Min | lung cysts/pneumothorax presentation of Birt-Hogg-Dubé Syndrome | — | — | ↑ | Min et al. (2020) |
| Tasena | COPD | — | — | ↑ | Tasena et al. (2018) |
| Gao | PF | TGF-ßRI | Mitigate PF | — | Gao et al. (2020) |